Saint Petersburg, Florida, September 1, 2026 – Stemedix has expanded its patient education resources with new content focused on regenerative therapy for chronic joint pain and early-stage joint degeneration. The latest educational initiative brings together current clinical research and physician-guided evaluation to help patients better understand how regenerative medicine treatment may support joint function and, for some individuals, delay the need for joint replacement surgery.
The announcement comes as more patients seek information about non-surgical treatment options for osteoarthritis and other degenerative joint conditions. While surgery remains the right choice for many people with advanced disease, physicians continue to evaluate regenerative medicine as a treatment option for patients whose condition has not reached end-stage degeneration.
Growing Demand for Regenerative Therapy Reflects the Burden of Chronic Joint Pain
Chronic joint pain continues to affect a large portion of the U.S. population. Data from the Centers for Disease Control and Prevention (CDC) show that 24.3% of U.S. adults experienced chronic pain in 2023, with 8.5% reporting high-impact chronic pain that regularly limited daily activities or work.
At the same time, the number of joint replacement procedures continues to rise. Research published in the Journal of Rheumatology projects that primary total knee replacement surgeries in the United States could reach approximately 1.9 million annually by 2030, reflecting the growing need for treatment options across different stages of joint disease.
These trends have increased interest in therapies that may help reduce pain, improve mobility, and support joint health before surgery becomes necessary.
How Regenerative Medicine Treatment Supports Joint Care
Unlike therapies that focus mainly on short-term symptom relief, regenerative medicine treatment aims to support the body's natural biological repair processes. The approach is designed to reduce inflammation within damaged joints, encourage tissue repair, and help slow further degeneration where medically appropriate.
Treatment recommendations are based on physician review of a patient's diagnosis, imaging studies, medical history, and current health status. Individuals are not evaluated based on symptoms alone, and not every patient is considered a candidate.
"Patients deserve clear, evidence-based information about every treatment option available to them," said Fred Palmer, CEO of Stemedix. "Our role is to support physician-led care by helping patients understand whether regenerative therapy may fit their individual diagnosis. Every recommendation begins with a careful review of medical records because every patient's condition is different."
Personalized Care Begins With Physician Evaluation
The clinic develops individualized treatment plans for patients who already have a confirmed diagnosis of conditions such as osteoarthritis, degenerative joint disease, degenerative disc disease, tendon injuries, ligament degeneration, radiculopathy, or facet syndrome.
Depending on the physician's assessment, treatment protocols may include Platelet-Rich Plasma (PRP), Prolozone Therapy, Ozone IV Therapy, or Mesenchymal Cell Therapy. Each plan is tailored to the patient's medical condition rather than following a standard treatment model.
Regenerative Therapy in Saint Petersburg, FL Focuses on Appropriate Patient Selection
Patients seeking regenerative therapy in Saint Petersburg, FL, receive care based on existing diagnostic records and physician evaluation. The clinic emphasizes that regenerative medicine is not intended to reverse severe joint destruction or replace surgery for patients with advanced disease. Instead, the goal is to identify patients who may benefit from a non-surgical treatment approach while preserving joint function for as long as medically appropriate.
Research Continues to Shape Regenerative Medicine
Clinical studies continue to examine the role of regenerative therapies in musculoskeletal care. Research evaluating Platelet-Rich Plasma (PRP) has reported improvements in pain relief and physical function for many patients with knee osteoarthritis over longer follow-up periods when compared with some conventional injection therapies.
While outcomes differ from one individual to another, the growing body of clinical evidence continues to support ongoing research into regenerative medicine and its role within comprehensive joint care.
About Stemedix
Stemedix is a regenerative medicine practice based in Saint Petersburg, Florida, providing physician-guided care for patients with diagnosed musculoskeletal and degenerative joint conditions. The practice develops personalized treatment plans using regenerative medicine therapies after reviewing each patient's medical records, diagnostic imaging, and health history. Located within the Bayfront Health Medical Building, the clinic also supports patients traveling from across the United States through transportation and accommodation coordination.
Media Contact
Fred Palmer
CEO, Stemedix
Bayfront Medical Plaza 601
7th Street S. Suite 565
Florida, Saint Petersburg 33701
Phone: (727) 456-8968
Email: yourjourney@stemedix.com
Contact Page: https://stemedix.com/contact/
